Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,884	11,411	9,583	4,890	8,811	-
Market Cap Growth	6.84%	19.08%	95.95%	-44.50%	-	-
Enterprise Value	13,411	12,107	9,772	4,726	8,238	-
Last Close Price	37.60	36.56	31.40	15.94	28.55	-
PE Ratio	23.33	28.22	58.81	37.88	76.36	-
Forward PE	17.68	20.25	50.65	31.86	30.20	-
PS Ratio	6.26	7.02	9.27	7.51	13.68	-
PB Ratio	3.79	4.25	4.38	2.54	4.87	-
P/TBV Ratio	4.28	4.76	5.04	2.95	5.64	-
P/OCF Ratio	22.98	28.52	27.36	166.95	48.75	-
EV/Sales Ratio	7.06	7.45	9.46	7.26	12.79	-
EV/EBITDA Ratio	15.86	18.27	30.27	27.72	41.45	-
EV/EBIT Ratio	22.98	26.27	51.15	65.84	70.35	-
Debt / Equity Ratio	0.82	0.61	0.41	0.17	0.05	0.26
Debt / EBITDA Ratio	3.06	2.45	2.74	1.86	0.41	1.23
Debt / FCF Ratio	-	-	-	-	-	8.24
Asset Turnover	0.34	0.38	0.34	0.28	0.37	0.43
Inventory Turnover	0.99	1.20	1.27	1.07	1.41	1.66
Quick Ratio	0.87	0.76	1.08	1.26	2.99	0.69
Current Ratio	1.34	1.14	1.54	1.91	4.01	1.28
Return on Equity (ROE)	17.16%	16.41%	8.04%	6.58%	7.84%	13.30%
Return on Assets (ROA)	6.55%	6.68%	3.93%	1.93%	4.15%	6.22%
Return on Invested Capital (ROIC)	11.97%	14.29%	8.82%	4.75%	8.90%	10.50%
Return on Capital Employed (ROCE)	12.60%	13.90%	7.40%	3.60%	6.30%	13.00%
Earnings Yield	4.20%	3.54%	1.70%	2.64%	1.31%	-
FCF Yield	-7.97%	-6.05%	-3.24%	-8.37%	-0.60%	-
Dividend Yield	1.72%	1.76%	0.91%	0.90%	0.38%	-
Payout Ratio	42.52%	29.37%	35.36%	31.43%	5.24%	-
Buyback Yield / Dilution	1.74%	-2.52%	-1.28%	-10.06%	-19.95%	1.06%
Total Shareholder Return	3.45%	-0.76%	-0.37%	-9.17%	-19.58%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.